VIable
HLCCompendium
HLCCompendium
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
NDHI<br />
NAT IONAL DIALOGUE FOR<br />
Healthcare Innovation<br />
Value Delivered<br />
In elective surgery patients, the IMPACT ® family of<br />
formulas has demonstrated the following reductions<br />
in risk: 8<br />
• Abdominal abscesses, by 54%<br />
• Urinary tract infections, by 47%<br />
• Anastomotic leaks, by 44%<br />
• Surgical site infections (SSIs), by 37%<br />
• 2-3 day decrease in length of stay (LOS)<br />
Health economics research has been published estimating<br />
the potential cost savings of implementing<br />
IMPACT ® immunonutrition in GI cancer surgeries.<br />
For a base complication rate of 20.8%, the use of<br />
IMPACT ® formulas peri-operatively is estimated to<br />
save the healthcare system approximately $2192 per<br />
patient stay. 9<br />
Path Forward<br />
• Nestlé Health Science is committed to advancing<br />
its breakthrough nutritional therapies in other areas,<br />
including Inherited Metabolic Disorders, Pediatric<br />
Care, Acute Care, Obesity Care, and Diabetic<br />
Neuropathy<br />
• Nutritional therapies have the potential to change<br />
the course of a patient’s condition, and Nestlé<br />
Health Science is committed to making nutritional<br />
therapies a more central part of the care management<br />
process<br />
8<br />
Waitzberg DL et al. Postsurgical infections are reduced with<br />
specialized nutrition support. World J Surg 2006;30:1592-1604.<br />
9<br />
Mauskopf JA et al. Immunonutrition for patients undergoing<br />
elective surgery for gastrointestinal cancer: impact on hospital<br />
costs. WJSO 2012:10:136.<br />
IMPACT ® and IMPACT Advanced Recovery ® are<br />
registered trademarks of Société des Produits<br />
Nestlé S.A., Vevey, Switzerland<br />
Improving Surgical Outcomes with Immunonutrition | 84